How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?

Marco Carbone, Jan Lerut, James Neuberger

Research output: Contribution to journalArticle

Abstract

The increasing shortage of donors and the adverse effects of immunosuppression have restricted the impact of solid organ transplantation. Despite the initial promising developments in xenotransplantation, roadblocks still need to be overcome and this form of organ support remains a long way from clinical practice. While hepatocyte transplantation may be effectively correct metabolic defects, it is far less effective in restoring liver function than liver transplantation. Tissue engineering, using extracellular matrix scaffolds with an intact but decellularized vascular network that is repopulated with autologous or allogeneic stem cells and/or adult cells, holds great promise for the treatment of failure of organs within gastrointestinal tract, such as endstage liver disease, pancreatic insufficiency, bowel failure and type 1 diabetes. Particularly in the liver field, where there is a significant mortality of patients awaiting transplant, human bioengineering may offer a source of readily available organs for transplantation. The use of autologous cells will mitigate the need for long term immunosuppression thus removing a major hurdle in transplantation.

Original languageEnglish
Pages (from-to)6908-6917
Number of pages10
JournalWorld Journal of Gastroenterology
Volume18
Issue number47
DOIs
Publication statusPublished - 2012

Fingerprint

Regenerative Medicine
Organ Transplantation
Gastroenterology
Tissue Engineering
Immunosuppression
Transplantation
Exocrine Pancreatic Insufficiency
Bioengineering
Heterologous Transplantation
Adult Stem Cells
Liver
Treatment Failure
Type 1 Diabetes Mellitus
Liver Transplantation
Extracellular Matrix
Blood Vessels
Gastrointestinal Tract
Liver Diseases
Hepatocytes
Tissue Donors

Keywords

  • Cellular transplantation
  • Organ transplantation
  • Regenerative medicine
  • Tissue engineering
  • Xenotransplantation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology? / Carbone, Marco; Lerut, Jan; Neuberger, James.

In: World Journal of Gastroenterology, Vol. 18, No. 47, 2012, p. 6908-6917.

Research output: Contribution to journalArticle

@article{f2bbe59d447b4ca999ca5b02e05f8a92,
title = "How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?",
abstract = "The increasing shortage of donors and the adverse effects of immunosuppression have restricted the impact of solid organ transplantation. Despite the initial promising developments in xenotransplantation, roadblocks still need to be overcome and this form of organ support remains a long way from clinical practice. While hepatocyte transplantation may be effectively correct metabolic defects, it is far less effective in restoring liver function than liver transplantation. Tissue engineering, using extracellular matrix scaffolds with an intact but decellularized vascular network that is repopulated with autologous or allogeneic stem cells and/or adult cells, holds great promise for the treatment of failure of organs within gastrointestinal tract, such as endstage liver disease, pancreatic insufficiency, bowel failure and type 1 diabetes. Particularly in the liver field, where there is a significant mortality of patients awaiting transplant, human bioengineering may offer a source of readily available organs for transplantation. The use of autologous cells will mitigate the need for long term immunosuppression thus removing a major hurdle in transplantation.",
keywords = "Cellular transplantation, Organ transplantation, Regenerative medicine, Tissue engineering, Xenotransplantation",
author = "Marco Carbone and Jan Lerut and James Neuberger",
year = "2012",
doi = "10.3748/wjg.v18.i47.6908",
language = "English",
volume = "18",
pages = "6908--6917",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "47",

}

TY - JOUR

T1 - How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?

AU - Carbone, Marco

AU - Lerut, Jan

AU - Neuberger, James

PY - 2012

Y1 - 2012

N2 - The increasing shortage of donors and the adverse effects of immunosuppression have restricted the impact of solid organ transplantation. Despite the initial promising developments in xenotransplantation, roadblocks still need to be overcome and this form of organ support remains a long way from clinical practice. While hepatocyte transplantation may be effectively correct metabolic defects, it is far less effective in restoring liver function than liver transplantation. Tissue engineering, using extracellular matrix scaffolds with an intact but decellularized vascular network that is repopulated with autologous or allogeneic stem cells and/or adult cells, holds great promise for the treatment of failure of organs within gastrointestinal tract, such as endstage liver disease, pancreatic insufficiency, bowel failure and type 1 diabetes. Particularly in the liver field, where there is a significant mortality of patients awaiting transplant, human bioengineering may offer a source of readily available organs for transplantation. The use of autologous cells will mitigate the need for long term immunosuppression thus removing a major hurdle in transplantation.

AB - The increasing shortage of donors and the adverse effects of immunosuppression have restricted the impact of solid organ transplantation. Despite the initial promising developments in xenotransplantation, roadblocks still need to be overcome and this form of organ support remains a long way from clinical practice. While hepatocyte transplantation may be effectively correct metabolic defects, it is far less effective in restoring liver function than liver transplantation. Tissue engineering, using extracellular matrix scaffolds with an intact but decellularized vascular network that is repopulated with autologous or allogeneic stem cells and/or adult cells, holds great promise for the treatment of failure of organs within gastrointestinal tract, such as endstage liver disease, pancreatic insufficiency, bowel failure and type 1 diabetes. Particularly in the liver field, where there is a significant mortality of patients awaiting transplant, human bioengineering may offer a source of readily available organs for transplantation. The use of autologous cells will mitigate the need for long term immunosuppression thus removing a major hurdle in transplantation.

KW - Cellular transplantation

KW - Organ transplantation

KW - Regenerative medicine

KW - Tissue engineering

KW - Xenotransplantation

UR - http://www.scopus.com/inward/record.url?scp=84873906532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873906532&partnerID=8YFLogxK

U2 - 10.3748/wjg.v18.i47.6908

DO - 10.3748/wjg.v18.i47.6908

M3 - Article

C2 - 23322988

AN - SCOPUS:84873906532

VL - 18

SP - 6908

EP - 6917

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 47

ER -